Loading
Eastwood Bio-Medical Canada Inc. Stock: price and insider trades · Canada
CA·Mcap CA$133.6M
Eastwood Bio-Medical Canada Inc.: what insiders have been doing
This page follows insider dealings at Eastwood Bio-Medical Canada Inc. as filed with SEDI. In the past year (18 October 2025 to 18 October 2026), 124 filings came from 3 insiders.
The record shows 49 purchases on the open market worth €25k, made by 3 insiders, against 74 sales worth €176k by 3 insiders. Sales outweigh purchases by €151k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 2 major shareholders and 1 senior executive. One trade stands out by size: a sale of €12k from Eastwood Bio-Medical Research Inc., disclosed on 31 August 2026, or 0.015% of market capitalisation.
Across the 2,121 companies tracked on its exchange, the median is 11 filings; at 124 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 49 purchases against 74 sales.
The latest purchase is recent: it was published 9 days ago, on 8 October 2026. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
124
Thresholds
n/a
Buy Volume
€25,242
49 ops. · all time
Sell Volume
€176,464
74 ops. · all time
Who traded when
BuySaleEastwood Bio-Medical Research Inc.17 buys53 sales
Yunji Kim29 buys21 sales
Cranewood Financial Corporation3 buys1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,446 of 24,148 companies
39.7
score / 100
Value34
Quality45
FCF yld0.0%
Earn yld-0.3%
EV/EBITDA·
ROE·
Gross mgn70%
Net mgn-43%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended October 2025 · cache
CA$1.94
Analyst consensus
Income statement
RevenueCA$782.1k
Gross profitCA$551k70% margin
EBITDA-CA$247.4k-32% margin
Net income-CA$332.8k-28.5% margin
Valuation
Beta0.32
Balance sheet & cash
Market capCA$133.6M
Total debtCA$78k
Free Cash FlowCA$19.3k
Profitability & ownership
ROA-47.2%
% insiders69.3%
% institutions0.0%
Last declaration on 10 October 2026
Declarations124 total
1,100 shares@ CA$1.980.0016% mcap0.8% of flowCommon SharesTSXSEDI:4789244
500 shares@ CA$1.980.0007% mcap0.4% of flowCommon SharesTSXSEDI:4789242
Canonical exit: 4 Jan 2027 (T+90)
1,700 shares@ CA$2.000.0025% mcap1.3% of flowCommon SharesTSXSEDI:4786980
Canonical exit: 31 Dec 2026 (T+90)
1,000 shares@ CA$1.980.0014% mcap0.8% of flowCommon SharesTSXSEDI:4786979
Canonical exit: 31 Dec 2026 (T+90)
4,400 shares@ CA$1.880.0066% mcap3.2% of flowCommon SharesTSXSEDI:4777224
5,000 shares@ CA$1.850.0074% mcap3.6% of flowCommon SharesTSXSEDI:4777223
5,000 shares@ CA$1.870.0075% mcap3.7% of flowCommon SharesTSXSEDI:4774988
5,000 shares@ CA$1.850.0074% mcap3.6% of flowCommon SharesTSXSEDI:4774984
5,000 shares@ CA$1.890.0075% mcap3.7% of flowCommon SharesTSXSEDI:4774983
10,000 shares@ CA$1.920.015% mcap7.5% of flowCommon SharesTSXSEDI:4770499
5,000 shares@ CA$1.900.0076% mcap3.7% of flowCommon SharesTSXSEDI:4768083
5,000 shares@ CA$1.850.0074% mcap3.6% of flowCommon SharesTSXSEDI:4768081
5,000 shares@ CA$1.900.0075% mcap3.7% of flowCommon SharesTSXSEDI:4766332
5,000 shares@ CA$1.850.0073% mcap3.6% of flowCommon SharesTSXSEDI:4766331
25 of 124 declarations
About Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. is a company focused on the biomedical sector, providing innovative solutions for the Canadian market. It is listed on the Toronto Stock Exchange (XTSE).
